Deregulated Cdk5 activity is involved in inducing Alzheimer's disease

Shukla, Varsha, Skuntz, Susan, Pant, Harish C.·2012·Archives of Medical Research

Cited by (185)

Items 101–185 of 185

  1. Cyclin-dependent kinase 5/Collapsin response mediator protein 2 pathway may mediate sevoflurane-induced dendritic development abnormalities in rat cortical neurons
    Yafang Liu, Daowei Lin, Chuiliang Liu, Yifan Zhao, Zhiwen Shen, Kun Zhang, Minghui Cao, Yujuan Li · 2017 · Neuroscience Letters
  2. Phosphorylation, Dephosphorylation, and Multiprotein Assemblies Regulate Dynamic Behavior of Neuronal Cytoskeleton: A Mini-Review
    Natalya A. Kurochkina, Manju Bhaskar, Sharda Prasad Yadav, Harish C. Pant · 2018 · Frontiers in Molecular Neuroscience
  3. Synaptic Organizers in Alzheimer’s Disease: A Classification Based on Amyloid-β Sensitivity
    Lee, Alfred Kihoon, Khaled, Husam, Chofflet, Nicolas, Takahashi, Hideto · 2020 · Frontiers in Cellular Neuroscience
  4. Synthesis, in vitro biological evaluation and in silico molecular docking study of hydroxy‑quinoline based sulfonohydrazide derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors
    Abdullah Yahya Abdullah Alzahrani, Hayat Ullah, Fazal Rahim, Fahad Khan, Abdul Wadood, Muhammad Taha, Amal H. Al-Bagawi, Mohamed A. Fareid, Mohamed S. Othman · 2024 · Journal of Molecular Structure
  5. 9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model
    Yaojun Ju, Kin Yip Tam · 2020 · Neuropharmacology
  6. Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges
    Chenxi He, Jinying Gu, Danni Wang, Keran Wang, Yuxuan Wang, Qidong You, Lei Wang · 2023 · European Journal of Medicinal Chemistry
  7. Aldehyde dehydrogenase 1 family: A potential molecule target for diseases
    Xiangning Duan, Haoliang Hu, Lingzhi Wang, Linxi Chen · 2024 · Cell Biology International
  8. Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein
    Balachandran Krishnamma Binukumar, Varsha Shukla, Niranjana D. Amin, Manju Bhaskar, Suzanne Skuntz, Joseph P. Steiner, Dirk F. H. Winkler, Steven Pelech, Harish C. Pant · 2015 · Journal of Alzheimer s Disease
  9. Structural Basis for the Different Stability and Activity between the Cdk5 Complexes with p35 and p39 Activators
    Taro Saito, Masashi Yano, Yusei Kawai, Akiko Asada, Mitsuhito Wada, Hirofumi Doi, Shin‐ichi Hisanaga · 2013 · Journal of Biological Chemistry
  10. Prenatal alcohol exposure alters p35, CDK5 and GSK3β in the medial frontal cortex and hippocampus of adolescent mice
    Samantha L. Goggin, Kevin K. Caldwell, Lee Anna Cunningham, Andrea M. Allan · 2014 · Toxicology Reports
  11. Suppression of neuroinflammation in forebrain-specific Cdk5 conditional knockout mice by PPARγ agonist improves neuronal loss and early lethality
    Elías Utreras, Ryusuke Hamada, Michaela Prochazkova, Anita Terse, Satoru Takahashi, Toshio Ohshima, Ashok B. Kulkarni · 2014 · Journal of Neuroinflammation
  12. α‑lipoic acid attenuates spatial learning and memory impairment induced by hepatectomy
    Yuan Zhang, Yun‐Luo Lv, Yanna Si, Jianwei Zhou, Yanning Qian, Hongguang Bao · 2019 · Experimental and Therapeutic Medicine
  13. hnRNPA2/B1 and nELAV proteins bind to a specific U-rich element in CDK5R1 3′-UTR and oppositely regulate its expression
    Paola Zuccotti, Claudia Colombrita, Silvia Moncini, Andrea Barbieri, Marta Lunghi, Cecilia Gelfi, Sara De Palma, Angelo Nicolin, Antonia Ratti, Marco Venturin et al. · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  14. Retinoic acid increases glucocorticoid receptor phosphorylation via cyclin-dependent kinase 5
    Julie Brossaud, Hélène Roumes, Jean‐Christophe Helbling, Marie‐Pierre Moisan, Véronique Pallet, Guillaume Ferreira, Essi F. Biyong, Anabelle Redonnet, Jean‐Benoît Corcuff · 2017 · Molecular and Cellular Neuroscience
  15. Hexa (ethylene glycol) derivative of benzothiazole aniline promotes dendritic spine formation through the RasGRF1–Ras dependent pathway
    Nathanael J. Lee, Jung Min Song, Hyun-Ji Cho, You Me Sung, Taehee Lee, Andrew Chung, Sung‐Ha Hong, Jessica L. Cifelli, Mark Rubinshtein, Lila K. Habib et al. · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  16. Design, Synthesis, in vitro biological evaluation and in silico molecular docking study of chloro substituted Benzimidazole-Thiazole hybrid derivatives as potential Anti-Alzheimer’s agents
    Sana Kaleem, Hayat Ullah, Muhammad Nabi, Rafaqat Hussain, Shoaib Khan, Muhammad Sajid, Naveed Iqbal, Fazal Rahim, Tayyiaba Iqbal, Amjad Hussain et al. · 2024 · Results in Chemistry
  17. RETRACTED ARTICLE: The Crucial Role of Cyclin-Dependent Kinase-5-Ataxia-Telangiectasia Mutated Axis in ICH-Induced Neuronal Injury of Rat Model
    Jing Wu, Xin Zhang, Yi Yan, Zhaohua Tang, Xiaochuan Sun, Gang Huo, Zhengbu Liao · 2015 · Molecular Neurobiology · Retracted
  18. Novel miR-sc4 regulates the proliferation and migration of Schwann cells by targeting Cdk5r1
    Tianmei Qian, Xinghui Wang, Yaxian Wang, Pan Wang, Qianyan Liu, Jie Liu, Sheng Yi · 2018 · Molecular and Cellular Biochemistry
  19. Gene Network Construction from Microarray Data Identifies a Key Network Module and Several Candidate Hub Genes in Age-Associated Spatial Learning Impairment
    Raihan Uddin, Shiva M. Singh · 2017 · Frontiers in Systems Neuroscience
  20. Amyloid-β Fosters p35/CDK5 Signaling Contributing to Changes of Inhibitory Synapses in Early Stages of Cerebral Amyloidosis
    Éva Kiss, Femke L. Groeneweg, Karin Gorgas, Andrea Schlicksupp, Stefan Kins, Joachim Kirsch, Jochen Kuhse · 2020 · Journal of Alzheimer s Disease
  21. Xenobiotics, Trace Metals and Genetics in the Pathogenesis of Tauopathies
    Jan Aaseth, Aleksandra Buha Djordjević, David R. Wallace, Geir Bjørklund · 2020 · International Journal of Environmental Research and Public Health
  22. P25/CDK5-mediated Tau Hyperphosphorylation in Both Ipsilateral and Contralateral Cerebra Contributes to Cognitive Deficits in Post-stroke Mice
    Jing Hua Yu, Yang Zhao, Xiaokang Gong, Zheng Liang, Yanna Zhao, Xin Li, Yu‐Ju Chen, Youhua Yang, Mengjuan Wu, Xiaochuan Wang et al. · 2023 · Current Medical Science
  23. Targeting a Tau Kinase Cdk5, Cyclin-Dependent Kinase: A Blood-Based Diagnostic Marker and Therapeutic Earmark for Alzheimer’s Disease
    Sakshi Kumari, Abhinay Kumar Singh, Mukesh Kumar, Rashmita Pradhan, Abhijith Rajaram Rao, Yudhishthir Yadav, Pramod Kumar, Partha Haldar, Punit Kaur, Sharmistha Dey · 2025 · Biomolecules
  24. PI3K/Akt inhibition promotes AR activity and prostate cancer cell proliferation through p35-CDK5 modulation
    Wei-Hsiang Kao, Kun‐Yuan Chiu, Stella Chin‐Shaw Tsai, Chieh‐Lin Jerry Teng, Muhammet Oner, Chih‐Ho Lai, Jer‐Tsong Hsieh, Chi‐Chen Lin, Hsin‐Yi Wang, Mei‐Chih Chen et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  25. Deep learning‐based segmentation in MRI ‐(immuno)histological examination of myelin and axonal damage in normal‐appearing white matter and white matter hyperintensities
    Gemma Sole Guardia, Matthijs Luijten, Esther Janssen, Ruben Visch, Bram Geenen, Benno Küsters, Jurgen A.H.R. Claassen, Geert J. S. Litjens, Frank‐Erik de Leeuw, Maximilian Wiesmann et al. · 2024 · Brain Pathology
  26. Natural Products Targeting Tau Protein Phosphorylation: A Promising Therapeutic Avenue for Alzheimerʼs Disease
    Ziying Chen, Lu Yan, Yiyun Wang, Qi Wang, Liangwen Yu, Jinman Liu · 2025 · Planta Medica
  27. The Unveiling of Therapeutic Targets for Alzheimer’s Disease: An Integrative Review
    Pratiksha R. Madar, Pooja Prabhu Nagalapur, Somdatta Y. Chaudhari, Devesh Sharma, Akshada Amit Koparde, Rahul Subhash Buchade, Sandip S. Kshirsagar, Pravin Shantaram Uttekar, Shailaja B. Jadhav, P. Chaudhari · 2024 · Current Topics in Medicinal Chemistry
  28. Optimizing gene selection for Alzheimer’s disease classification: A Bayesian approach to filter and embedded techniques
    Bouchra Guelib, Rayene Bounab, Salah Eddine Aliouane, Haithem Hermessi, Nawrès Khlifa, Karim Zarour · 2024 · Applied Soft Computing
  29. Amino acid sequence conservation of the algesic fragment of myelin basic protein is required for its interaction with CDK 5 and function in pain
    Andrei V. Chernov, Albert G. Remacle, Swathi K. Hullugundi, Piotr Cieplak, Mila Angert, Jennifer Dolkas, Veronica I. Shubayev, Alex Y. Strongin · 2018 · FEBS Journal
  30. PMINR: Pointwise Mutual Information-Based Network Regression – With Application to Studies of Lung Cancer and Alzheimer’s Disease
    Weiqiang Lin, Jiadong Ji, Yuchen Zhu, Mingzhuo Li, Jinghua Zhao, Fuzhong Xue, Zhongshang Yuan · 2020 · Frontiers in Genetics
  31. Epibrassinolide prevents tau hyperphosphorylation via GSK3β inhibition in vitro and improves Caenorhabditis elegans lifespan and motor deficits in combination with roscovitine
    Pınar Obakan Yerlikaya, Elif Damla Arısan, Ajda Çoker Gürkan, Osman Orcun Okumus, Tuğba Yenigün Yazıcı, Utku Özbey, Melissa Kara, Narçın Palavan-Ünsal · 2021 · Amino Acids
  32. Investigating Pathogenetic Mechanisms of Alzheimer’s Disease by Systems Biology Approaches for Drug Discovery
    Shan‐Ju Yeh, Ming-Hsun Chung, Bor‐Sen Chen · 2021 · International Journal of Molecular Sciences
  33. EGCG modulates nuclear formaldehyde-induced Tau phosphorylation in Neuronal cells
    Shweta Kishor Sonawane, Anshu Raina, Amitabha Majumdar, Subashchandrabose Chinnathambi · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  34. Ginsenoside CK modulates glucose metabolism via PPARγ to ameliorate SCOP-induced cognitive dysfunction
    Na Li, Xingyu Fang, Hui Li, Jian Liu, Nan Chen, Xiaohui Zhao, Qing Yang, Xijun Chen · 2025 · Metabolic Brain Disease
  35. Neuronal CDK5RAP3 deficiency leads to encephalo-dysplasia via upregulation of N-glycosylases and glycogen deposition
    Fanghui Chen, Minghui Xiang, Zhipeng Wang, Fan Yang, Junzhi Zhou, Zihan Deng, Susu Wang, Ping Li, Jieqi Tew, Wei Zhang et al. · 2025 · Cell Death Discovery
  36. Histone Deacetylase 2 in Alzheimer’s Disease: A Comprehensive Molecular Blueprint for Therapeutic Targeting
    Kavuma Asadi, Radha K., Sairaj Satarker, Prasada Chowdari Gurram · 2025 · Molecular Neurobiology
  37. Effects of Cerebrospinal Fluids from Alzheimer and Non-Alzheimer Patients on Neurons–Astrocytes–Microglia Co-Culture
    Matilda Iemmolo, Giulia Bivona, Tommaso Piccoli, Aldo Nicosia, Gabriella Schiera, Carlo Maria Di Liegro, Fabrizio Di Pietra, Giulio Ghersi · 2024 · International Journal of Molecular Sciences
  38. Design and Synthesis of 2-Substitutedphenyl Benzo[D]Thiazole Derivatives and Their β-Amyloid Aggregation and Cholinesterase Inhibitory Activities
    Merve Zengin, Oya Ünsal Tan, Tuba Tüylü Küçükkılınç, Beyza Ayazgök, Ayla Balkan · 2019 · Pharmaceutical Chemistry Journal
  39. Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
    Devank Shekho, Ritika Mishra, Raj Kamal, Rohit Bhatia, Ankit Awasthi · 2024 · AAPS PharmSciTech
  40. TFP5 prevents 1-methyl-4-phenyl pyridine ion-induced neurotoxicity in mouse cortical neurons
    Qi-Shan Zhang, Yuan-Gao Liao, Zhong Ji, Yong Gu, Haishan Jiang, Zuoshan Xie, Su-Yue Pan, Yafang Hu · 2016 · Experimental and Therapeutic Medicine
  41. From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer’s Disease Landscape
    Anastasia M. Bougea, Manuel Debasa‐Mouce, Shelly Gulkarov, Mónica Castro‐Mosquera, Allison Bethanne Reiss, Alberto Ouro · 2025 · Medicina
  42. Molecular and Therapeutic Targets for Amyloid-beta Plaques in Alzheimer's Disease: A Review Study
    Jaya Thomas, SAMSON KOOVAYIL WILSON · 2021 · Basic and Clinical Neuroscience Journal
  43. Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases
    Balachandran Krishnamma Binukumar, Steven Pelech, Catherine Sutter, Varsha Shukla, Niranjana D. Amin, Philip G. Grant, Manju Bhaskar, Suzanne Skuntz, Joseph P. Steiner, Harish C. Pant · 2016 · Journal of Alzheimer s Disease
  44. Functional and molecular early enteric biomarkers for Parkinson’s disease in mice and men
    Manuela Gries, Anne Christmann, Steven Schulte, Maximilian Weyland, Stephanie Rommel, Monika Martin, Marko K. Baller, Ralph Röth, Stefanie Schmitteckert, Marcus Michael Unger et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  45. The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
    Yvonne Bouter · 2015
  46. Ptprd deficiency promotes tau hyperphosphorylation and impairs cognitive function in aged mice
    Analia Foncea-Bitrán, Nayhara Franchini, Isidora Tobar, Sebastián Thienel, Ignacio N. Retamal, Gonzalo I. Cancino, Francisca Cornejo · 2025 · Biological Research
  47. Protective Effect of Hydroxysafflor Yellow A against Chronic Mild Stress-induced Memory Impairments by Suppressing Tau Phosphorylation in Mice
    Ying Wang, Qiang Wang, Jun Chen, Lihe Yao, Ni Tang, Zhenxiu Jiang, Yu Luo · 2021 · Current Medical Science
  48. Interstitial microdeletion of 17q11.2 is associated with hypotonia, fatigue, intellectual disability, and a subtle facial phenotype in three unrelated patients
    Deborah Osio, Julia Rankin, Hannele Koillinen, Adele Reynolds, Hilde Van Esch · 2017 · American Journal of Medical Genetics Part A
  49. Transient enhancement of proliferation of neural progenitors and impairment of their long-term survival in p25 transgenic mice
    Donghua Zou, Yijing Zhou, Long Liu, Fengping Dong, Tianzhi Shu, Ying Zhou, Li‐Huei Tsai, Yingwei Mao · 2016 · Oncotarget
  50. Collapsin Response Mediator Protein 2 (CRMP2) Modulates Mitochondrial Oxidative Metabolism in Knock-In AD Mouse Model
    Tatiana Brustovetsky, Rajesh Khanna, Nickolay Brustovetsky · 2025 · Cells
  51. Multi-kinase-mediated alterations in Tau phosphorylation, synaptic proteins, and choline metabolism in a human neuronal in vitro model exposed to the elastin-derived hexapeptide VGVAPG
    Bartosz Skóra, Tomasz Piechowiak, Konrad A. Szychowski · 2025 · Neuropharmacology
  52. Cyclin-dependent kinases (CDKs) are key genes regulating early development of Neptunea arthritica cumingii: evidence from comparative transcriptome and proteome analyses
    Fengxiao Lv, Xinfan Ge, Yaqing Chang, Zhenlin Hao · 2024 · BMC Genomics
  53. Design, Synthesis, Characterization and In Vitro Evaluation of Anticholinesterase and Antioxidant Activities of Thiazole–Piperazine Sulphonamide Hybrids
    Kethineni Sajitha, Kandrakonda Yelamanda Rao, Valaparla Bala Yesu, Chandran Remya, Kalarickal Vijayan Dileep, V.V.P.C. Narayana, Shaik Jeelan Basha, Vamsi Katta, Donka Suresh Babu, Murali Vatturu et al. · 2025 · Chemistry & Biodiversity
  54. Signaling molecules and disturbances of cognitive functions in brain diseases
    О. А. Гомазков · 2015 · Neurochemical Journal
  55. Alzheimer's Disease Protein Targets: Comprehensive Review and Future Directions
    B.S. Hemanth Kumar, Basavana Gowda Hosur Dinesh, Sandra Ross Olakkengil Shajan, Nandini Markuli Sadashivappa, Damodar Nayak Ammunje, Selvaraj Kunjiappan, Panneerselvam Theivendren, Parasuraman Pavadai · 2024 · Current Pharmaceutical Design
  56. Hydrogen sulfide in the brain as a silent neuroprotector in Alzheimer’s disease
    Himanshu Layal, Jitumani Rajbongshi, Rohit Kumar, Shambhavi Pandey, Rajeev Mishra, Pramod Kumar Yadav · 2025 · Neuroscience
  57. Immunotherapeutics for AD: A Work in Progress
    Anuja Sharma, Jaspreet Singh Anand, Yatender Kumar · 2021 · CNS & Neurological Disorders - Drug Targets
  58. Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats
    Camilla A. Molobekova, Elena M. Kondaurova, Tatiana V. Ilchibaeva, Alexander Ya. Rodnyy, Natalia A. Stefanova, Nataliya G. Kolosova, Vladimir S. Naumenko · 2023 · Current Alzheimer Research
  59. An in-silico study to identify potent phytochemicals for reducing neurotoxicity triggered by calpain and CDK5/p25 complex
    Mahir Azmal, Jibon Kumar Paul, Omar Faruk Talukder, A.N.M Shah Newaz Been Haque, Ajit Ghosh · 2025 · Computers in Biology and Medicine
  60. BmCDK5 Affects Cell Proliferation and Cytoskeleton Morphology by Interacting with BmCNN in Bombyx mori
    Yi Wei, Xiaolin Zhou, Peng Chen, Xia Jiang, Ziyi Jiang, Zhanqi Dong, Min‐Hui Pan, Cheng Lu · 2022 · Insects
  61. Investigation of the Effect of Peptide p5 Targeting CDK5-p25 Hyperactivity on Munc18–1 (P67) Regulating Neuronal Exocytosis Using Molecular Simulations
    Tejaswi Tammareddy, Walid Keyrouz, Ram D. Sriram, Harish C. Pant, Antonio Cardone, Jeffery B. Klauda · 2024 · Biochemistry
  62. Network mechanism analysis between hippocampal development and Alzheimer's disease
    Shuo Xu, Zhi-Tao Liu, Xin-Yue Yang, Xuan Huang-Fu, Biao Yue, Xin-Hui Tang · 2025 · New medicine.
  63. Navigating the kinases landscape: Impact on regulated cell death mechanisms in neurodegenerative disorders
    Heba Mohamed Mansour, Aiman Saad El-Khatib · 2025 · Elsevier eBooks
  64. Signaling molecules in the brain and epigenetic factors in neurodegenerative and mental disorders
    О. А. Гомазков · 2015 · S S Korsakov Journal of Neurology and Psychiatry
  65. Serotonin receptors - a potential target for the treatment of Alzheimer’s disease
    Dmitry V. Eremin, Elena M. Kondaurova, Alexander Ya. Rodnyy, K. A Molobekova, Dmitry Anatolievich Kudlay, Vladimir S. Naumenko · 2023 · Biochemistry (Moscow)
  66. Retraction Note to: The Crucial Role of Cyclin-Dependent Kinase-5-Ataxia-Telangiectasia Mutated Axis in ICH-Induced Neuronal Injury of Rat Model
    Jing Wu, Xin Zhang, Yi Yan, Zhaohua Tang, Xiaochuan Sun, Gang Huo, Zhengbu Liao · 2017 · Molecular Neurobiology · Retracted
  67. An Integrative View on Intra- and Inter-Cellular Cooperation Mechanisms in Alzheimer's Disease
    Ana‐Maria Enciu, C. I. Parhon, Victor Babes · 2014
  68. Roles of the Insulin-like Growth Factor-II/Cation-independent Mannose 6-phosphate Receptor and Cathepsin D in Alzheimer’s Disease Pathology
    Yanlin Wang · 2016 · ERA: Education and Research Archive (University of Alberta)
  69. The relation between human biomarkers and oxidative stress in Alzheimer’s disease, novel in vivo experimental modelling possibilities
    Zita Galik-Olah · 2018
  70. Decoding the Epigenome of Neuronal Networks in Health and Disease
    Gaurav Jain · 2019
  71. N-truncated Aβ4-x peptides in Alzheimer's disease: generation, degradation, and relationship with neuropathological hallmarks
    Silvia Zampar · 2021
  72. Unconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile
    Marı́a Contel · 2019 · MDPI eBooks
  73. Young serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration
    Kaihua Guo, Fangfang Qi, Zejie Zuo, Kaishun Hu, Rui Wang, Tong Wu, Hao Liu, Jiaoling Tang, Qingbo Wang, Yufeng Xie et al. · 2022 · Research Square
  74. A Review on the Research Progress of Mechanism of Panax ginseng C. A. meyer in the Treatment of Alzheimer’s Disease
    Meng Zhang, Meng Ge, Qingqing Li, Hui Li, Lili Jiao, Wei Wu · 2023 · Preprints.org
  75. Cdk5 activation promotes Cos-7 cells transition towards neuronal-like cells
    Li Bao, Xiao-Mei Lan, Guoqing Zhang, Xi Bao, Bo Li, Dan-Na Ma, Hongyan Luo, Shilu Cao, Shunyao Liu, Enxuan Jing et al. · 2023 · Translational Neuroscience
  76. Capturing biomarkers associated with Alzheimer disease subtypes using data distribution characteristics
    Kenneth D. Smith, Sharlee Climer · 2024 · Frontiers in Computational Neuroscience
  77. Detection of the Alzheimer's disease soluble amyloid precursor protein and modulation of its proteolytic processing
    Taverna, Mara · 2014 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
  78. Collapsin Response Mediator Protein 2 (CRMP2) Modulates Induction of the Mitochondrial Permeability Transition Pore in a Knock-In Mouse Model of Alzheimer’s Disease
    Tatiana Brustovetsky, Rajesh Khanna, Nickolay Brustovetsky · 2026 · Cells
  79. Association of genetic variants in cyclin-dependent kinase 5 with Alzheimer's disease in a Saudi cohort
    Safia A. Messaoudi, Abrar B. Alsaleh, Lama A. AlSalem, Saranya Rameshbabu, Sachil Kumar, Mourad Assidi, Khaled Ouanes, Vera A. Chayeb, Hédia Zitouni, Wassim Youssef Almawi · 2026 · Journal of Alzheimer s Disease
  80. Development of fluorescent biosensors for probing CDK/Cyclin activity in vitro and in cellulo
    Ngoc Bui Van · 2013
  81. Influences biochimiques, anatomiques et cognitives de la troncation exopeptidasique N-terminale du peptide Aβ
    Audrey Valverde · 2020 · theses.fr (ABES)
  82. The emerging role of polo-like kinase 2 in Alzheimer's disease
    Laura Martínez-Drudis, Razan Sheta, Dylan Musiol, Maxime Teixeira, Abid Oueslati · 2026 · Experimental Neurology
  83. THERAPY FOR ALZHEIMER’S DISEASE - FOCUS ON LECANEMAB
    Mikołaj Jońca, Gabriela Majchrowicz, Natasza Kurys, Weronika Piekarska, Szymon Litke, Katarzyna Gołacka · 2026 · International Journal of Innovative Technologies in Social Science
  84. An age-preserving neuronal iSpheroid platform for modeling human aging and Alzheimer’s disease
    Samhan Alsolami, Meiyan Wang, Thaís S. Sabedot, Upendra Singh, Brian Kirk, Lisa E. Mitchell, Melissa Hernandez, Nicholas J. Skvir, Chynna Bowman, Kotaro Oiwa et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  85. BindingDB Entry 50021669: Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges.
    BindingDB · 2025 · UC San Diego